Navigation Links
Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence
Date:11/11/2009

Finland, November 11 /PRNewswire/ --

- This is a third party press release. It will be issued by the Finnish Breast Cancer Group on Wednesday 11 November 2009.

- FinXX, a Large, Phase III Randomised Study in Women With Early Breast Cancer Shows that Adding Capecitabine (Xeloda(R)) to a Treatment Regimen Containing Standard Agents Allows More Women to Live Cancer-Free for Longer

An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34% reduction in the risk of the disease returning or death, compared with those taking the chemotherapy combination regimen without capecitabine.

The pre-planned three-year interim analysis of a randomised, prospective trial (known as FinXX) compared adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for the treatment of early breast cancer with the standard, non-capecitabine regimen (docetaxel, epirubicin, cyclophosphamide and fluorouracil).[1] The analysis also found that patients taking the capecitabine-containing regimen were significantly less likely to have their cancer spread (distant metastasis) to another part of the body (a 36% reduction in risk was observed). This is the first phase III randomised trial to report efficacy of capecitabine combination therapy in the adjuvant treatment of early breast cancer.

"Capecitabine has already been shown to be effective in patients with advanced breast cancer. In addition, these results from the FinXX study show that using a capecitabine-containing regimen in the early stages of breast cancer may offer survival benefits for women, which is a primary goal of treatment," said Professor Heikki Joensuu, Principal Investigator, Helsinki University Hospital, Finland. "I am e
'/>"/>

SOURCE The Finnish Breast Cancer Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
2. Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet
3. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
4. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
5. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
6. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
7. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
8. Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing
9. Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
10. Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
11. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... , Feb. 9 LIVESTRONG ... and print-on-demand publication from LIVE STRONG .  The magazine ... against cancer; resources and information about cancer prevention and ... ,, "As a three-time cancer survivor, I understand ... personal level," said LIVE STRONG President and CEO ...
(Date:2/9/2010)... Volcano Corporation (Nasdaq: VOLC ... intravascular therapy guidance tools designed to enhance the ... disease, announced today that it has acquired the ... Biomedical. Volcano became the exclusive global distributor of ... This acquisition reinforces Volcano,s dedication to build a ...
(Date:2/9/2010)... 9 Glycemion Strategies, Inc., an ... for diabetic consumers and their professional healthcare providers, ... Program to benefit the 30,000 US Diabetes Educators ... they serve. ,, The Portrait Health™ ... to provide real-time access to health information, especially ...
Breaking Medicine Technology:SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 49774 1Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 49774 2Ontario women live longer but dont prosper 3A Study 49770 1Ontario women live longer but dont prosper 3A Study 49770 2Ontario women live longer but dont prosper 3A Study 49770 3Ontario women live longer but dont prosper 3A Study 49770 4Energy saving method checks refrigerant level in air conditioners 8970 1Energy saving method checks refrigerant level in air conditioners 8970 2
... BOSTON, Oct. 6 "A return to the ... is without scientific,justification," according to a paper released ... "An Assessment of the Role of,Chimpanzees in AIDS ... not predictive of responses in humans, and that ...
... Collaborate to Improve Patient Safety, WASHINGTON, ... in collaboration with the American College of ... consensus guidelines,outlining a stepwise approach for reducing ... among patients using nonsteroidal,anti-inflammatory drugs (NSAIDs) along ...
Other Medicine Technology:Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4
(Date:2/9/2010)... vitamin D begins in the womb, expert says, , , ... mothers who drink lots of milk and have a ... a much lower risk of developing multiple sclerosis later ... 35,794 U.S. nurses whose mothers provided information about their ... for 16 years, and 199 of them developed multiple ...
(Date:2/9/2010)... blood pressure restrict fetal growth, study finds, , , TUESDAY, ... bring into pregnancy can have lasting effects on your ... found that women who smoked, had high blood pressure ... babies that were smaller in the first trimester of ... , "Our study demonstrates that several maternal physical characteristics ...
(Date:2/9/2010)... Insurer-favored ,Cost Solution,: Selling Policies That Amount To ,A ... WASHINGTON , Feb. 9 Blue ... with its premium hikes of up to 39% in ... of questions from the White House and an investigation ... lawmakers should act to regulate health insurance premiums and ...
(Date:2/9/2010)... , Feb. 9 ... J. James Rohack , M.D., President, American ... ,, "The American Medical Association is ... Obama in the Let,s Move Campaign. ... have long worked to address obesity and ...
(Date:2/9/2010)... Institute and the Sanford-Burnham Medical Research Institute have ... owned member of the Roche group, and Roche, ... develop and market human monoclonal antibodies to treat ... viruses include the strains for the current seasonal ... a non-exclusive right to manufacture, develop and market ...
Breaking Medicine News(10 mins):Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... of parents will be required by teenagers in Scotland who ... tattoo studios will also be subject to mandatory licensing// to ... to all those who are less than 16 years of ... the possibilities of blood borne diseases being transmitted through contaminated ...
... mother Bernadette Mimura, belonging to Ingleby Barwick Ingleby Barwick who ... disease//. She had refused life-saving treatment as it involved making ... the unborn baby, by the doctors. ,Being a ... a mild form of chemotherapy treatment with the object of ...
... to feel happy about the way he looks by just looking ... looks great he is convinced//. ,Women on the other ... difficult to satisfy them unless they are supplemented with actual results. ... was conducted by Kathleen Martin Ginis, associate professor of kinesiology at ...
... that moderate exercise has positive benefits on the hearts, ... studies in the last 10 to 20 years have ... people suffering from congestive heart failure. ,However, the ... to be statistically significant. ,In the new study ...
... on the Gulf of Carpentaria in Australia has triggered concerns ... virus//. ,However, the Australian Quarantine and Inspection Service ... they were sending out a team as a precautionary measure, ... a military operative has also started towards the island. "There's ...
... has been found to be effective in treatment of ... benefited from vitamin treatment as found by researchers from ... intervention wherein patients not responsive to steroid treatment after ... ,Professor Tak Lee, Director of the MRC-Asthma UK ...
Other Medicine News:Health News:Asthma an be treated with Vitamin supplement intervention 2
... Every Bard® Biopsy Instrument and Needle ... one important goal: a large quality, reliable ... exceptional performance, featuring ultra-sharp tips and polished ... broad selection of biopsy systems and needle ...
... Needle is specially designed to help you ... reliable core sample. All needles are engineered ... polished surfaces for smooth entry and exit. ... needle sizes assures an ideal match with ...
... designed to bring efficiency and quality to ... the superior technology of fluorescent flow cytometry ... Continuous sampling or batch processing are easily ... processing in high volume laboratories. Fluorescent ...
... Cartridge System is a single-use, disposable needle ... spacers into a Bard BrachyStar needle for ... outer radiation safety shield, inner compartment that ... molded fitting that connects the cartridge to ...
Medicine Products: